About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Pennsylvania | 414 Studies

Clinical Trials Pancreatic CancerPennsylvania

Pancreatic Cancer Clinical Trials in Pennsylvania

Find 414 clinical trials for pancreatic cancer near Pennsylvania. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 414 trials

RecruitingAdaptive Radiation for Locally Advanced Unresectable Pancreatic CancerThe goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.NCT06984562·Philadelphia, Pennsylvania CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00026403·Scottsdale, Arizona and 25 others

Active not recruitingTesting the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsThis phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline…NCT04548752·Anchorage, Alaska and 532 others

RecruitingA Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsThis clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors.NCT04657068·Birmingham, Alabama and 81 others

TerminatedA Study of Ruxolitinib in Pancreatic Cancer PatientsThis was to determine the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of metastatic pancreatic cancer.NCT02119663·Huntsville, Alabama and 94 others

CompletedSapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by SurgeryThis phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the body (metastatic), does…NCT02893930·Phoenix, Arizona and 404 others

CompletedFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerThis randomized phase II trial studies how well modified irinotecan hydrochloride, leucovorin calcium, fluorouracil (FOLFIRI) and veliparib as a second line of therapy work…NCT02890355·Mobile, Alabama and 782 others

TerminatedSEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive JaundiceThis trial studies the side effects of self expanding metal stent (SEMS) placement before surgery in unblocking the bile duct in patients with periampullary pancreatic cancer with…NCT03820544·Philadelphia, Pennsylvania

CompletedA Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerThe purpose of this study is to determine if imexon in combination with gemcitabine could improve overall survival as compared to gemcitabine alone in subjects with pancreatic…NCT00637247·Birmingham, Alabama and 47 others

CompletedAMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsRATIONALE: AMG 706 and octreotide may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00427349·Berwyn, Illinois and 111 others

RecruitingCarcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenA Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of…NCT07087054·Gilbert, Arizona and 72 others

Active not recruitingA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerSubjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT).NCT03899636·Miami, Florida and 5 others

CompletedA Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic AdenocarcinomaThis is a randomized, open-label, multi-center, phase 3 study of napabucasin plus weekly nab-paclitaxel with gemcitabine versus weekly nab-paclitaxel with gemcitabine for adult…NCT02993731·Birmingham, Alabama and 266 others

Active not recruitingStudy of LP-184 in Patients With Advanced Solid TumorsThe primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory…NCT05933265·Springdale, Arkansas and 6 others

CompletedPEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerThis study is designed to compare the treatment effect of PEGPH20 combined with nab-paclitaxel (NAB) and gemcitabine (GEM) \[PAG\] to NAB and GEM \[AG\] in participants with Stage…NCT01839487·Birmingham, Alabama and 50 others

CompletedTrial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersThe main purpose of this study is to determine how best to combine hypofractionated radiotherapy, MEDI4736, and tremelimumab and to determine how safe and tolerable…NCT02639026·Philadelphia, Pennsylvania

CompletedGemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryThis randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy regimen with or without radiation…NCT01013649·Mobile, Alabama and 688 others

CompletedPembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsThis is an open-label, multicenter, Phase 1b platform study in subjects with advanced or metastatic solid tumors (Part 1a) and subjects with selected solid tumors (Part 1b and…NCT02646748·San Francisco, California and 16 others

CompletedA Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsThe purpose of this study is to determine the recommended dose of siltuximab monotherapy, in participants with solid malignant (cancerous) tumors (a mass in a specific area) and…NCT00841191·Philadelphia, Pennsylvania and 11 others

PreviousPage 2 of 21Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia